Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
RECRUITING
NCT06509503
PHASE4

Impact of Combined Oral Contraceptive Pills on Migraine

Sponsor: Kafrelsheikh University

View on ClinicalTrials.gov

Summary

The investigators will assess the effect of combined oral contraceptive pills (COCs) on migraine features and treatment response to allow better interpretation of the exact consequence of hormonal contraceptive use on migraineurs.

Official title: Impact of Combined Oral Contraceptive Pills on Migraine, a Randomized Controlled Trial

Key Details

Gender

FEMALE

Age Range

18 Years - 55 Years

Study Type

INTERVENTIONAL

Enrollment

400

Start Date

2024-07-15

Completion Date

2025-07-30

Last Updated

2024-10-09

Healthy Volunteers

No

Conditions

Interventions

DRUG

Combined oral contraceptive

The arm will include 200 migraine patients diagnosed according to ICHD3-beta criteria. The patients are regular users of COCs and will receive propranolol 80-160mg daily and ibuprofen 200-400 mg only in acute migraine attacks for 3 months.

DRUG

Vaginal Ring

The arm will include 200 migraine patients diagnosed according to ICHD3-beta criteria. The patients are users of mechanical contraceptive methods and will receive propranolol 80-160mg daily and ibuprofen 200-400 mg only in acute migraine attacks for 3 months.

Locations (1)

Kafr Elsheikh University Hospital

Kafr ash Shaykh, Egypt